Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Immuron (ANWA) Stock Price & Analysis

0 Followers

ANWA Stock Chart & Stats

€0.74€0.04(4.23%)
At close: 5:30 PM GMT+1
€0.925€0.95€0.975Sep 29Oct 7
Day’s Range
EUR 0.71 - EUR 0.74
52-Week Range
EUR 0.49 - EUR 1.53
Previous Close
EUR 0.71
Volume
N/A
Average Volume (3M)
200
Market Cap
EUR 6.77M
Enterprise Value
EUR 2.31M
Total Cash (Recent Filing)
EUR 9.02M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
―
Beta
-0.01
Next Earnings
Feb 19, 2027 (Est.)
EPS Estimate
-0
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Commercialization Traction

Revenue expansion over several years shows that Immuron has moved beyond a purely developmental model and achieved meaningful commercialization. This supports the durability of its marketed product base and provides a larger platform from which future pipeline products could scale.

Gross Margin

A gross margin near 64% indicates that product-level economics are comparatively solid, even though operating expenses remain too high for profitability. This creates a foundation for future operating leverage if revenue grows and development or corporate costs become more efficient.

Debt-Free Balance Sheet

The absence of debt reduces refinancing pressure, mandatory interest obligations, and balance-sheet risk while the company funds its commercial and clinical activities. Meaningful equity and assets provide some financial cushion and preserve flexibility for strategic decisions.

Bears Say

Persistent Unprofitability

Immuron remains materially unprofitable despite having a marketed product and improving results versus earlier periods. Continued operating losses limit internally generated capital, weaken returns on equity, and make a durable transition to self-funded growth dependent on stronger revenue or lower costs.

Negative Cash Generation

Consistently negative operating and free cash flow means the business is consuming cash rather than funding its own development and commercialization. Although burn improved from 2025, ongoing cash deficits still imply continued financing needs if profitability does not improve.

Revenue Volatility

The 2026 revenue contraction demonstrates that prior commercialization gains have not yet translated into a consistently expanding revenue base. Such volatility makes planning and operating leverage less dependable, and it reduces confidence that the company is close to sustained profitability.

Immuron News

ANWA FAQ

What was Immuron’s price range in the past 12 months?
Immuron lowest stock price was €0.49 and its highest was €1.53 in the past 12 months.
What is Immuron’s market cap?
Immuron’s market cap is €6.77M.
When is Immuron’s upcoming earnings report date?
Immuron’s next earnings report is estimated for Feb 19, 2027 (not yet confirmed), which is in 99 days.
How were Immuron’s earnings last quarter?
Immuron released its earnings results on Aug 27, 2026. The company reported -€0.004 earnings per share for the quarter.
Is Immuron overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Immuron pay dividends?
Immuron does not currently pay dividends.
What is Immuron’s EPS estimate?
Immuron’s EPS estimate is -0.00.
How many shares outstanding does Immuron have?
Immuron has 8,071,202 shares outstanding.
What happened to Immuron’s price movement after its last earnings report?
Immuron reported an EPS of -€0.004 in its last earnings report. Following the earnings report the stock price went up 2.151%.
Which hedge fund is a major shareholder of Immuron?
Currently, no hedge funds are holding shares in DE:ANWA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology